Michael A Kamm

Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease

Philippe Marteau, Jacques Cosnes, P. Rutgeerts, 2009, Inflammatory bowel diseases.

Psychological state and quality of life in patients having behavioral treatment (biofeedback) for intractable constipation

M. Kamm, E. Serrano-Ikkos, Michael A Kamm, 2002, American Journal of Gastroenterology.

Cinical, physiological, and radiological study of a new purpose-designed artifical bowel sphincter

Steve Halligan, M. Kamm, S. Halligan, 1998, The Lancet.

Primary degeneration of the internal anal sphincter as a cause of passive faecal incontinence

M. Kamm, C. Bartram, Clive I Bartram, 1997, The Lancet.

Microbial-gut interactions in health and disease. Interactions between dendritic cells and bacteria in the regulation of intestinal immunity.

M. Kamm, A. Hart, A. Stagg, 2004, Best practice & research. Clinical gastroenterology.

Association between specific mucosa‐associated microbiota in Crohn's disease at the time of resection and subsequent disease recurrence: A pilot study

Chris McSweeney, Josef Wagner, Trevor Lockett, 2015, Journal of gastroenterology and hepatology.

Randomized controlled trial of biofeedback for fecal incontinence.

Sally Redfern, M. Kamm, J. Wilson‐Barnett, 2003, Gastroenterology.